Prostaglandins and cycloxygenases in the spinal cord

Progress in Neurobiology

Volumn 64, Issue 4, 2001, Pages 327-363

  Vanegas, Horacio ^a,b,c   Schaible, Hans Georg ^b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Centro Biofisica/Bioquimica   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EXCITATORY AMINO ACID; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; SUBSTANCE P; TETRODOTOXIN; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ALLODYNIA; ANTINOCICEPTION; CALCIUM TRANSPORT; DISEASE SEVERITY; DRUG EFFECT; HUMAN; HYPERALGESIA; INFLAMMATION; MEMBRANE CURRENT; MUSCLE SPINDLE AFFERENT NERVE; NEUROTRANSMITTER RELEASE; NOCICEPTION; NOCICEPTIVE STIMULATION; POTASSIUM CURRENT; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REVIEW; SODIUM CURRENT; SPINAL CORD INJURY; SPINAL CORD NERVE CELL; SYNAPTIC TRANSMISSION; ANIMAL; DRUG POTENTIATION; METABOLISM; PAIN ASSESSMENT; SPINAL CORD; SPINAL GANGLION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GANGLIA, SPINAL; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PAIN MEASUREMENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN; SPINAL CORD;

EID: 0035081365     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(00)00063-0     Document Type: Review

References (178)

1. Inhibition of prostaglandin synthesis in rat brain
2. Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the spinal cord in vitro
3. Expression of tetrodotoxin-resistant sodium channels in capsaicin-sensitive dorsal root ganglion neurons of adult rats
4. Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: Arachidonic acid and its metabolites as second messengers
5. Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells
6. Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid
7. Central analgesic effects of aspirin-like drugs
8. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation
9. Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis
10. 2 receptor EP3 in the rat lumbar spinal cord
11. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action
12. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
13. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes
14. Accumulation and apparent active transport of prostaglandins by some rabbit tissues in vitro
15. Impermeability of rabbit erythrocytes to prostaglandins
16. Central, naloxone-reversible antinociception by diclofenac in the rat
17. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P
18. 2 prostanoid receptor subtypes
19. New evidence for an additional (central) site of action of antipyretic analgesics
20. Effects of intrathecal or intracerebral administration of nonsteroidal ant-inflammatory drugs on a C-fiber reflex in rats
21. Lipid-derived autacoids. Eicosanoids and platelet-activating factor
22. Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone)
23. Depression by morphine and the non-opioid analgesic agents metamizol (dipyrone), lysine acetylsalicylate, and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents
24. The capsaicin receptor: A heat-activated ion channel in the pain pathway
25. Impaired nociception and pain sensation in mice lacking the capsaicin receptor
26. The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat
27. Biopharmazeutische und pharmakokinetische Untersuchungen nach Gabe von Metamizol-14C (NovalginR 14C) an Ratte, Hund und Mensch
28. Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism
29. Noxious stimulus-induced increase in spinal prostaglandin E2 is noradrenergic terminal-dependent
30. 2-induced potentiation of bradykinin excitation in rat sensory neurons
31. The distribution of certain non-narcotic analgetic agents in the CNS of several species
32. Small intrathecal doses of lysine-acetylsalicylate relieve intractable pain in man
33. In vitro prostanoid release from spinal cord following peripheral inflammation: Effects of substance P, NMDA and capsaicin
34. 2 release
35. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carageenan-evoked thermal hyperalgesia in rats
36. Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man
37. N-methyl D-aspartate induced mechanical allodynia is blocked by nitric oxide synthase and cyclooxygenase-2 inhibitors
38. Activity-dependent neuronal plasticity following tissue injury and inflammation
39. Intraspinal release of immunoreactive prostaglandins without and during development of acute inflammation in the rat knee joint
40. 2 in a model of acute arthritis is accompanied by up-regulation of cyclo-oxygenase-2 in the spinal cord
41. 2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase cascade
42. Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons
43. 2-induced inhibition of potassium currents in rat sensory neurons
44. Prostaglandins, aspirin-like drugs and analgesia
45. Prostaglandins: Peripheral and central analgesia
46. Intrathecal administration of prostaglandin E2 causes sensitization of primary afferent neurons via the spinal release of glutamate
47. Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs
48. New insights into the site and mode of antinociceptive action of flurbiprofen enantiomers
49. Prostanoid synthesis in the spinal cord enhances excitability of dorsal horn convergent neurones during reperfusion of ischaemic receptive fields on the rat's tail
50. Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro
51. + current in nociceptors
52. 2-induced sensitization of cultured rat sensory neurons
53. 2-induced sensitization of rat sensory neurons in vitro
54. Cyclooxygenase-2 in the spinal cord: Localization and regulation after a peripheral inflammatory stimulus
55. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kB activation
56. 2 production and reduced early thermal hyperalgesia in iNOS-deficient mice
57. COX-2 inhibitors
58. Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal cord
59. Dexamethasone prevents the induction of COX-2 mRNA and prostaglandins in the lumbar spinal cord following intraplantar FCA in parallel with inhibition of oedema
60. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia
61. Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons
62. Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade
63. 2 release
64. 2 and amino acids
65. Interleukin-1 (induces substance P release from primary afferent neurons through the cyclooxygenase-2 system
66. Dipyrone into the nucleus raphe magnus inhibits the rat nociceptive tail-flick reflex
67. Acetylsalicylic acid and related compounds depress nociceptive activity in the thalamus by a central action: Indications for the involvement of prostaglandins
68. Opioid and nonopioid analgesic agents: Some aspects of central (spinal) and peripheral actions
69. Central effect of the non-steroid anti-inflammatory agents, indometacin, ibuprofen, and diclofenac, determined in C fibre- evoked activity in single neurones of the rat thalamus
70. Intrathecal injection of acetylsalicylic acid, salicylic acid and indomethacin depresses C fibre-evoked activity in the rat thalamus and spinal cord
71. Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase
72. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex
73. Cyclooxygenases and the central nervous system
74. Expression of prostaglandin EP2 receptor mRNA in the rat spinal cord
75. Inhibition of NF-kB by sodium salicylate and aspirin
76. Effect of non-nacotic analgesics on membrane permeability of molluscan neurons
77. Site of action of narcotic and non-narcotic analgesics determined by blocking bradykinin-evoked visceral pain
78. Central antinociceptive effects of meloxicam on rat spinal cord in vitro
79. 2-mediated sensitization of the capsaicin response in rat sensory neurons
80. 2 enhancement of the capsaicin-elicited current in rat sensory neurons: Whole-cell and single-channel studies
81. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat
82. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition
83. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction
84. Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test
85. 2 release in spinal cord slices: Relative effect of cyclooxygenase inhibitors
86. 2 and amino acids evoked by paw formalin injection: A microdialysis study in unanesthetized rats
87. 2 using microdialysis in conscious rats
88. Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat
89. 2 and capsaicin on behavior and cerebrospinal fluid amino acid concentrations of unanesthetized rats: A microdialysis study
90. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions
91. Substance P-induced release of prostaglandins from astrocytes: Regional specialization and correlation with phosphoinositol metabolism
92. 2 binding sites in rat brain using quantitative autoradiography
93. 3H| iloprost
94. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing
95. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs
96. Salicylates and phospholipid bilayer membranes
97. 2 and generation of cyclooxygenase products
98. The induction of pain: An integrative review
99. 2α to conscious mice
100. 2 to mice
101. 2α injected into conscious mice
102. 2 to conscious mice
103. 2α in conscious mice
104. 2
105. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice
106. Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2
107. 2
108. 2 release after peripheral noxious stimulation
109. Prostanoid receptors: Structures, properties, and functions
110. Molecular mechanisms of diverse actions of prostanoid receptors
111. Electrophysiological evidence for a spinal antinociceptive action of dipyrone
112. Antinociceptive effects of R(-)- and S(+)-flurbiprofen on rat spinal dorsal horn neurons rendered hyperexcitable by an acute knee joint inflammation
113. 2 of bradykinin activation of embryonic rat sensory neurons
114. 2 increases calcium conductance and stimulates release of substance P in avian sensory neurons
115. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons
116. 2-induced hyperalgesia in conscious mice
117. 2 stimulates glutamate release from synaptosomes of rat spinal cord
118. Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury
119. Interleukin-1 ( induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte culture
120. Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: Relation to lipid solubility
121. In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs
122. Glutamate receptors in the mammalian central nervous system
123. 2 production
124. Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat
125. Douleur chronique rebelle des cancereux
126. Mediation and modulation by eicosanoids of responses of spinal dorsal horn neurons to glutamate and substance P receptor agonists: Results with indomethacin in the rat in vivo
127. NSAID-induced cyclooxygenase inhibition differentially depresses long-lasting versus brief synaptically-elicited responses of rat spinal dorsal horn neurons in vivo
128. 50 values in mice
129. Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model
130. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance
131. 2 receptors in the chicken spinal cord: 2. Radioautographic localization
132. Spontaneous and evoked release of prostaglandins from frog spinal cord
133. Role of cyclooxygenase 2 in acute spinal cord injury
134. Prostaglandin potentiates acid-induced release of CGRP from cultures DRG neurons
135. Further studies on the actions of salicylates on nerve membranes
136. Molecular mechanism of neuronal prostaglandin release
137. 1 produces a long-lasting allodynic state
138. 2
139. On the role of tachykinins and calcitonin gene-related peptide in the spinal mechanisms of nociception and in the induction and maintenance of inflammation-evoked hyperexcitability in spinal cord neurons (with special reference to nociception in joints)
140. Afferent and spinal mechanisms of joint pain
141. The effects of S- and R-flurbiprofen on the inflammation-evoked intraspinal release of immunoreactive substance P: A study with antibody microprobes
142. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
143. Characterization of prostanoid receptors on rat sensory neurons
144. 2)
145. 2 receptors in rat dorsal spinal cord
146. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices
147. 2 increases the proportion of neonatal rat dorsal root ganglion neurons that respond to bradykinin
148. 3 in the mouse nervous system
149. Intrathecal injection of lysine acetylsalicylic acid in the rat: A neurotoxicological study
150. 2α
151. Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses
152. Possible involvement of interleukin-1 in cyclooxygenase-2 induction after spinal cord injury in rats
153. Putative role of medullary off- and on-cells in the antinociception produced by dipyrone (metamizol) administered systemically or microinjected into PAG
154. Antinociception induced by systemic or PAG-microinjected lysine-acetylsalicylate in rats. Effects on tail-flick related activity of medullary off- and on-cells
155. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2alpha to conscious mice
156. Modulation of spinal excitability: Co-operation between neurokinin and excitatory amino acid neurotransmitters
157. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
158. Cyclooxygenases 1 and 2
159. PAG-microinjected dipyrone (metamizol) inhibits responses of spinal dorsal horn neurons to natural noxious stimulation in rats
160. Prostaglandin-induced neuropeptide release from spinal cord
161. Prostaglandins stimulate the release of substance P from rat spinal cord slices
162. 2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture
163. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro
164. 2 by fibroblasts and nonneuronal cells in chick dorsal root ganglia
165. 2 by motoneurons and dorsal horn microneurons: A biochemical and high resolution immunocytochemical study in chick spinal cord
166. Neuronal and glial prostaglandin D synthase isozymes in chick dorsal root ganglia: A light and electron microscopic immunohistochemical study
167. Antinociception without motor blockade after subarachnoid administration of S-(+)-ibuprofen in rats
168. Prostanoids synthetized by cyclooxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability
169. Central plastic responses to pain
170. 2 is suggested by distribution studies of the rat DP prostanoid receptor
171. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
172. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor
173. Analysis of the roles of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission
174. Role of spinal cyclooxygenase (COX)-2 on thermal hyperalgesia evoked by carrageenan injection in the rat
175. COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA
176. E-type prostaglandins depolarize primary afferent neurons of the neonatal rat
177. 2 release after carrageenan/kaolin-induced knee joint inflammation: A chronic microdialysis study
178. 2 release in rat